The Amyloidosis Channel is supported with funding from Prothena (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMW 2019 | Amyloidosis: diagnosis and stem cell transplantation
Vaishali Sanchorawala, MD, Boston University School of Medicine, Boston, MA, Morie Gertz, MD, MACP, Mayo Clinic College of Medicine, Rochester, MN, and Raymond Comenzo MD, Tufts University School of Medicine, Boston, MA, discuss the current treatment approach to amyloidosis. They explain the importance of accurate diagnosis, the necessity of determining the amyloid precursor protein, and debate whether stem cell transplant is still useful in the age of novel therapies. This roundtable was held at the International Myeloma Workshop (IMW) 2019, in Boston, MA.
